These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24341816)

  • 1. The road ahead: working towards effective clinical translation of myocardial gene therapies.
    Katz MG; Fargnoli AS; Williams RD; Bridges CR
    Ther Deliv; 2014 Jan; 5(1):39-51. PubMed ID: 24341816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.
    Scimia MC; Cannavo A; Koch WJ
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):999-1013. PubMed ID: 23984926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy: targeting the myocardium.
    Lyon AR; Sato M; Hajjar RJ; Samulski RJ; Harding SE
    Heart; 2008 Jan; 94(1):89-99. PubMed ID: 18083952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of heart gene delivery vectors.
    Wasala NB; Shin JH; Duan D
    J Gene Med; 2011 Oct; 13(10):557-65. PubMed ID: 21837689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac gene therapy in large animals: bridge from bench to bedside.
    Ishikawa K; Tilemann L; Ladage D; Aguero J; Leonardson L; Fish K; Kawase Y
    Gene Ther; 2012 Jun; 19(6):670-7. PubMed ID: 22301438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Cardiac Surgery with Recirculating Delivery (MCARD): Procedure and Vector Transfer.
    Katz MG; Fargnoli AS; Kendle AP; Bridges CR
    Methods Mol Biol; 2017; 1521():271-289. PubMed ID: 27910057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
    Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
    J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing gene delivery vectors for the treatment of heart disease.
    Gray SJ; Samulski RJ
    Expert Opin Biol Ther; 2008 Jul; 8(7):911-22. PubMed ID: 18549322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to improve cardiac gene therapy expression.
    Scimia MC; Sydnes KE; Zuppo DA; Koch WJ
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1317-26. PubMed ID: 25340284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation.
    Rincon MY; VandenDriessche T; Chuah MK
    Cardiovasc Res; 2015 Oct; 108(1):4-20. PubMed ID: 26239654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond small molecule drugs for heart failure: prospects for gene therapy.
    Chien KR
    Novartis Found Symp; 2006; 274():244-56; discussion 256-9, 272-6. PubMed ID: 17019816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac gene therapy: optimization of gene delivery techniques in vivo.
    Katz MG; Swain JD; White JD; Low D; Stedman H; Bridges CR
    Hum Gene Ther; 2010 Apr; 21(4):371-80. PubMed ID: 19947886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous control of cardiac gene therapy: evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters.
    Lee LY; Zhou X; Polce DR; El-Sawy T; Patel SR; Thakker GD; Narumi K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):26-4, discussion 34-5. PubMed ID: 10384181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of gene and cellular therapies for heart disease.
    Mariani JA; Kaye DM
    J Cardiovasc Transl Res; 2010 Aug; 3(4):417-26. PubMed ID: 20559776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral-based myocardial gene therapy approaches to alter cardiac function.
    Williams ML; Koch WJ
    Annu Rev Physiol; 2004; 66():49-75. PubMed ID: 14977396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene delivery methods in cardiac gene therapy.
    Ishikawa K; Tilemann L; Fish K; Hajjar RJ
    J Gene Med; 2011 Oct; 13(10):566-72. PubMed ID: 21954037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split vector systems for ultra-targeted gene delivery: a contrivance to achieve ethical assurance of somatic gene therapy in vivo.
    Tolmachov OE
    Med Hypotheses; 2014 Aug; 83(2):211-6. PubMed ID: 24854575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals.
    Kaye DM; Preovolos A; Marshall T; Byrne M; Hoshijima M; Hajjar R; Mariani JA; Pepe S; Chien KR; Power JM
    J Am Coll Cardiol; 2007 Jul; 50(3):253-60. PubMed ID: 17631218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.